

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 6.08841231 |
| 2 | regulation of activation of Janus kinase activity (GO:0010533) | 5.99780422 |
| 3 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 5.50042875 |
| 4 | regulation of chronic inflammatory response (GO:0002676) | 5.45304309 |
| 5 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.91785262 |
| 6 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.79065432 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.78702599 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 4.56279024 |
| 9 | T-helper 1 type immune response (GO:0042088) | 4.55114980 |
| 10 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.55050506 |
| 11 | regulation of podosome assembly (GO:0071801) | 4.53599856 |
| 12 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.50913175 |
| 13 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.47709061 |
| 14 | regulation of RIG-I signaling pathway (GO:0039535) | 4.47657926 |
| 15 | negative regulation of interleukin-12 production (GO:0032695) | 4.46656092 |
| 16 | type I interferon signaling pathway (GO:0060337) | 4.42920259 |
| 17 | cellular response to type I interferon (GO:0071357) | 4.42920259 |
| 18 | * response to peptidoglycan (GO:0032494) | 4.42478896 |
| 19 | response to interferon-beta (GO:0035456) | 4.36267727 |
| 20 | response to type I interferon (GO:0034340) | 4.36227997 |
| 21 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 4.35017151 |
| 22 | positive regulation of heat generation (GO:0031652) | 4.33088049 |
| 23 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.31525457 |
| 24 | regulation of fever generation (GO:0031620) | 4.26663945 |
| 25 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 4.22044817 |
| 26 | cellular response to interferon-alpha (GO:0035457) | 4.21505978 |
| 27 | positive regulation of interleukin-17 production (GO:0032740) | 4.15017887 |
| 28 | positive regulation of interferon-alpha production (GO:0032727) | 4.13276765 |
| 29 | regulation of heat generation (GO:0031650) | 4.09357738 |
| 30 | superoxide anion generation (GO:0042554) | 4.08679581 |
| 31 | natural killer cell activation involved in immune response (GO:0002323) | 4.03988110 |
| 32 | negative regulation of viral genome replication (GO:0045071) | 4.02714303 |
| 33 | cellular response to interferon-beta (GO:0035458) | 3.94481917 |
| 34 | reactive oxygen species biosynthetic process (GO:1903409) | 3.93961300 |
| 35 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.93387971 |
| 36 | regulation of memory T cell differentiation (GO:0043380) | 3.92338685 |
| 37 | regulation of interferon-alpha production (GO:0032647) | 3.88433091 |
| 38 | granulocyte activation (GO:0036230) | 3.82409903 |
| 39 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.81437261 |
| 40 | * positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.80322705 |
| 41 | response to interferon-alpha (GO:0035455) | 3.80222525 |
| 42 | activation of MAPKKK activity (GO:0000185) | 3.79480416 |
| 43 | modulation by symbiont of host defense response (GO:0052031) | 3.79359341 |
| 44 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.79359341 |
| 45 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.79359341 |
| 46 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.79359341 |
| 47 | modulation by symbiont of host immune response (GO:0052553) | 3.79359341 |
| 48 | positive regulation by symbiont of host defense response (GO:0052509) | 3.79359341 |
| 49 | positive regulation of p38MAPK cascade (GO:1900745) | 3.79135833 |
| 50 | * regulation of nitric oxide biosynthetic process (GO:0045428) | 3.78896265 |
| 51 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.78210945 |
| 52 | negative regulation of interleukin-17 production (GO:0032700) | 3.77882681 |
| 53 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.72483650 |
| 54 | * regulation of chemokine biosynthetic process (GO:0045073) | 3.69764975 |
| 55 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.67084709 |
| 56 | positive regulation of interleukin-12 production (GO:0032735) | 3.66259918 |
| 57 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.61537600 |
| 58 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.60889971 |
| 59 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.54249868 |
| 60 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.48606997 |
| 61 | neutrophil activation (GO:0042119) | 3.48406962 |
| 62 | regulation of interleukin-17 production (GO:0032660) | 3.47356460 |
| 63 | NIK/NF-kappaB signaling (GO:0038061) | 3.45793634 |
| 64 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.45268075 |
| 65 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.44071150 |
| 66 | eosinophil chemotaxis (GO:0048245) | 3.43326209 |
| 67 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.42200153 |
| 68 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.42056456 |
| 69 | adhesion of symbiont to host cell (GO:0044650) | 3.39018323 |
| 70 | virion attachment to host cell (GO:0019062) | 3.39018323 |
| 71 | * positive regulation of T-helper cell differentiation (GO:0045624) | 3.38084359 |
| 72 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.36777413 |
| 73 | cellular response to nicotine (GO:0071316) | 3.36573753 |
| 74 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.36166376 |
| 75 | respiratory burst (GO:0045730) | 3.36024881 |
| 76 | response to nitrosative stress (GO:0051409) | 3.34914457 |
| 77 | regulation of NF-kappaB import into nucleus (GO:0042345) | 3.34475538 |
| 78 | lymphocyte chemotaxis (GO:0048247) | 3.34222932 |
| 79 | * cellular response to lipopolysaccharide (GO:0071222) | 3.33627327 |
| 80 | cellular response to exogenous dsRNA (GO:0071360) | 3.33179416 |
| 81 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.32363580 |
| 82 | immunoglobulin mediated immune response (GO:0016064) | 3.32331217 |
| 83 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.31138598 |
| 84 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.30410079 |
| 85 | macrophage activation involved in immune response (GO:0002281) | 3.29841491 |
| 86 | positive regulation of response to biotic stimulus (GO:0002833) | 3.29521117 |
| 87 | positive regulation of lymphocyte migration (GO:2000403) | 3.28162249 |
| 88 | * positive regulation of acute inflammatory response (GO:0002675) | 3.24620854 |
| 89 | xenobiotic catabolic process (GO:0042178) | 3.24255360 |
| 90 | * positive regulation of type 2 immune response (GO:0002830) | 3.22568513 |
| 91 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.22484201 |
| 92 | natural killer cell mediated immunity (GO:0002228) | 3.22484201 |
| 93 | detection of molecule of bacterial origin (GO:0032490) | 3.22185464 |
| 94 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.21663150 |
| 95 | positive regulation of defense response to virus by host (GO:0002230) | 3.20332740 |
| 96 | leukocyte aggregation (GO:0070486) | 3.19624520 |
| 97 | * cellular response to molecule of bacterial origin (GO:0071219) | 3.18633444 |
| 98 | positive regulation of transcription factor import into nucleus (GO:0042993) | 3.17493984 |
| 99 | germinal center formation (GO:0002467) | 3.16915946 |
| 100 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.13415576 |
| 101 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.12318856 |
| 102 | * positive regulation of interleukin-6 production (GO:0032755) | 3.11322227 |
| 103 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.10286768 |
| 104 | regulation of mononuclear cell migration (GO:0071675) | 3.07698814 |
| 105 | T cell migration (GO:0072678) | 3.05526791 |
| 106 | decidualization (GO:0046697) | 3.05524700 |
| 107 | regulation of vitamin metabolic process (GO:0030656) | 3.03190087 |
| 108 | * defense response to protozoan (GO:0042832) | 3.02157011 |
| 109 | response to muramyl dipeptide (GO:0032495) | 3.01737823 |
| 110 | eosinophil migration (GO:0072677) | 3.00676599 |
| 111 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.00135461 |
| 112 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.99662998 |
| 113 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 2.98754563 |
| 114 | * monocyte chemotaxis (GO:0002548) | 2.97857967 |
| 115 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.94931273 |
| 116 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.93925636 |
| 117 | cellular response to zinc ion (GO:0071294) | 2.93760329 |
| 118 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.93454052 |
| 119 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.92699514 |
| 120 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.91315570 |
| 121 | positive regulation of interferon-beta production (GO:0032728) | 2.91138776 |
| 122 | regulation of T-helper 1 type immune response (GO:0002825) | 2.90736905 |
| 123 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.89649835 |
| 124 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.89491195 |
| 125 | myeloid dendritic cell differentiation (GO:0043011) | 2.89355323 |
| 126 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.89298772 |
| 127 | response to manganese ion (GO:0010042) | 2.88750618 |
| 128 | positive regulation of T cell mediated immunity (GO:0002711) | 2.87432612 |
| 129 | regulation of interleukin-12 production (GO:0032655) | 2.87053092 |
| 130 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.86969348 |
| 131 | ovulation (GO:0030728) | 2.86514581 |
| 132 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.86229989 |
| 133 | regulation of growth of symbiont in host (GO:0044126) | 2.86229989 |
| 134 | cell adhesion mediated by integrin (GO:0033627) | 2.84046357 |
| 135 | chronic inflammatory response (GO:0002544) | 2.81707037 |
| 136 | negative regulation of growth of symbiont in host (GO:0044130) | 2.81414738 |
| 137 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.81414738 |
| 138 | * regulation of vascular endothelial growth factor production (GO:0010574) | 2.80981775 |
| 139 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.80623810 |
| 140 | adhesion of symbiont to host (GO:0044406) | 2.80075108 |
| 141 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.79934283 |
| 142 | * cellular response to biotic stimulus (GO:0071216) | 2.77686942 |
| 143 | * regulation of immunoglobulin secretion (GO:0051023) | 2.75206207 |
| 144 | negative regulation of amino acid transport (GO:0051956) | 2.73809003 |
| 145 | * positive regulation of chemokine production (GO:0032722) | 2.70830179 |
| 146 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.70334147 |
| 147 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.68587793 |
| 148 | * regulation of interleukin-6 production (GO:0032675) | 2.64994139 |
| 149 | * response to protozoan (GO:0001562) | 2.63885656 |
| 150 | positive regulation of astrocyte differentiation (GO:0048711) | 2.62171704 |
| 151 | * negative regulation of lipid storage (GO:0010888) | 2.62098212 |
| 152 | * regulation of T-helper cell differentiation (GO:0045622) | 2.62043769 |
| 153 | response to vitamin D (GO:0033280) | 2.58783614 |
| 154 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.57288537 |
| 155 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.56774015 |
| 156 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.54611674 |
| 157 | * regulation of type 2 immune response (GO:0002828) | 2.54359243 |
| 158 | negative regulation of glucose transport (GO:0010829) | 2.53844141 |
| 159 | positive regulation of natural killer cell activation (GO:0032816) | 2.51339807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 9.75651741 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.23755403 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.23575755 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.76270446 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.11916298 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.60123280 |
| 7 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.59853840 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.58153888 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.37002041 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.12938765 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.06473688 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.88904958 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.54474625 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.39975185 |
| 15 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.38909419 |
| 16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.34776282 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.14027564 |
| 18 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.07199140 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.06012590 |
| 20 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.01727427 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.96493353 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.96175035 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.92013085 |
| 24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.78118594 |
| 25 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.57058433 |
| 26 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.57058433 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.51018796 |
| 28 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.50201596 |
| 29 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.49431359 |
| 30 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48470212 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.46804705 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.44973331 |
| 33 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.41953246 |
| 34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.39528669 |
| 35 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36839033 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35876821 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.35441978 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.34272356 |
| 39 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.31847836 |
| 40 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.28020367 |
| 41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28011722 |
| 42 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27366939 |
| 43 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.25183408 |
| 44 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.24672958 |
| 45 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23934770 |
| 46 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.23410601 |
| 47 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.23410601 |
| 48 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.23410601 |
| 49 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.23005056 |
| 50 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.21995827 |
| 51 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21941315 |
| 52 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.17012685 |
| 53 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.15644876 |
| 54 | MYB_26560356_Chip-Seq_TH2_Human | 1.14641675 |
| 55 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11160703 |
| 56 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.10805554 |
| 57 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09499717 |
| 58 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.08872351 |
| 59 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07939701 |
| 60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07082961 |
| 61 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.06809095 |
| 62 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04980037 |
| 63 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04856387 |
| 64 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03869140 |
| 65 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03683570 |
| 66 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03489874 |
| 67 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02500627 |
| 68 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.02425484 |
| 69 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00203853 |
| 70 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.99907981 |
| 71 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.98682054 |
| 72 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.98682054 |
| 73 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96741144 |
| 74 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.96712722 |
| 75 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95545693 |
| 76 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.94067390 |
| 77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93629041 |
| 78 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92774737 |
| 79 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.92360741 |
| 80 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91051415 |
| 81 | GATA1_22025678_ChIP-Seq_K562_Human | 0.90338397 |
| 82 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.90324156 |
| 83 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90271015 |
| 84 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89204544 |
| 85 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.88752941 |
| 86 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.88296260 |
| 87 | GATA3_26560356_Chip-Seq_TH2_Human | 0.87278728 |
| 88 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87179953 |
| 89 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.87047340 |
| 90 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86215638 |
| 91 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85431817 |
| 92 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85197740 |
| 93 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.80942928 |
| 94 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80126789 |
| 95 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79593011 |
| 96 | MYB_26560356_Chip-Seq_TH1_Human | 0.79491940 |
| 97 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.77949273 |
| 98 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.77681657 |
| 99 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.76887017 |
| 100 | KDM2B_26808549_Chip-Seq_K562_Human | 0.76170202 |
| 101 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75138152 |
| 102 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.75136017 |
| 103 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.72798984 |
| 104 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.70656218 |
| 105 | VDR_22108803_ChIP-Seq_LS180_Human | 0.70151229 |
| 106 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.69532050 |
| 107 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.68607543 |
| 108 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.66333459 |
| 109 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.65815359 |
| 110 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.64934914 |
| 111 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.64637023 |
| 112 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.64321564 |
| 113 | MAF_26560356_Chip-Seq_TH1_Human | 0.62029251 |
| 114 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.61384572 |
| 115 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.60098165 |
| 116 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.59861150 |
| 117 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.59757561 |
| 118 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.59190439 |
| 119 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.58150976 |
| 120 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.58006734 |
| 121 | RXR_22108803_ChIP-Seq_LS180_Human | 0.56484993 |
| 122 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.53872785 |
| 123 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.53784996 |
| 124 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.52931655 |
| 125 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.52641050 |
| 126 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.52369540 |
| 127 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.52328301 |
| 128 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.51985316 |
| 129 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.51758647 |
| 130 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.50668165 |
| 131 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.49829867 |
| 132 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.49410790 |
| 133 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.48953011 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0009785_altered_susceptibility_to | 4.83901300 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.65506747 |
| 3 | MP0003724_increased_susceptibility_to | 4.27434395 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 4.25669094 |
| 5 | MP0003436_decreased_susceptibility_to | 3.62133843 |
| 6 | * MP0006082_CNS_inflammation | 3.45396305 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.33630860 |
| 8 | MP0008004_abnormal_stomach_pH | 3.27750014 |
| 9 | * MP0002419_abnormal_innate_immunity | 3.19217062 |
| 10 | * MP0005025_abnormal_response_to | 3.11681182 |
| 11 | MP0009764_decreased_sensitivity_to | 2.70226742 |
| 12 | MP0003186_abnormal_redox_activity | 2.64580837 |
| 13 | MP0003303_peritoneal_inflammation | 2.57431096 |
| 14 | MP0000685_abnormal_immune_system | 2.50659832 |
| 15 | * MP0005387_immune_system_phenotype | 2.47150626 |
| 16 | * MP0001790_abnormal_immune_system | 2.47150626 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.44977586 |
| 18 | * MP0002452_abnormal_antigen_presenting | 2.42492212 |
| 19 | MP0002006_tumorigenesis | 2.40664184 |
| 20 | * MP0002723_abnormal_immune_serum | 2.38347715 |
| 21 | MP0009840_abnormal_foam_cell | 2.34190691 |
| 22 | MP0008438_abnormal_cutaneous_collagen | 2.32865594 |
| 23 | MP0005671_abnormal_response_to | 2.24297324 |
| 24 | MP0005167_abnormal_blood-brain_barrier | 2.19090416 |
| 25 | MP0001800_abnormal_humoral_immune | 2.16424247 |
| 26 | MP0001853_heart_inflammation | 2.11477112 |
| 27 | MP0003075_altered_response_to | 2.06379662 |
| 28 | MP0006054_spinal_hemorrhage | 2.03937223 |
| 29 | MP0004510_myositis | 2.01635627 |
| 30 | * MP0001819_abnormal_immune_cell | 1.99662053 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.94925662 |
| 32 | * MP0002420_abnormal_adaptive_immunity | 1.94102493 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.85694353 |
| 34 | MP0003448_altered_tumor_morphology | 1.85386210 |
| 35 | * MP0002332_abnormal_exercise_endurance | 1.83505650 |
| 36 | * MP0001845_abnormal_inflammatory_respons | 1.82676712 |
| 37 | MP0000858_altered_metastatic_potential | 1.82664456 |
| 38 | MP0002405_respiratory_system_inflammati | 1.77816158 |
| 39 | MP0005023_abnormal_wound_healing | 1.73788003 |
| 40 | MP0001542_abnormal_bone_strength | 1.72926944 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.70212358 |
| 42 | * MP0008469_abnormal_protein_level | 1.69387740 |
| 43 | MP0003195_calcinosis | 1.63831728 |
| 44 | * MP0004947_skin_inflammation | 1.63683731 |
| 45 | MP0003950_abnormal_plasma_membrane | 1.59845042 |
| 46 | MP0000343_altered_response_to | 1.54285255 |
| 47 | MP0005451_abnormal_body_composition | 1.48409592 |
| 48 | * MP0005166_decreased_susceptibility_to | 1.42455856 |
| 49 | MP0004782_abnormal_surfactant_physiolog | 1.42248784 |
| 50 | MP0009278_abnormal_bone_marrow | 1.42099257 |
| 51 | MP0002139_abnormal_hepatobiliary_system | 1.39263762 |
| 52 | * MP0005164_abnormal_response_to | 1.38526047 |
| 53 | MP0001346_abnormal_lacrimal_gland | 1.34750107 |
| 54 | MP0002877_abnormal_melanocyte_morpholog | 1.32007643 |
| 55 | MP0004883_abnormal_blood_vessel | 1.30431481 |
| 56 | MP0002295_abnormal_pulmonary_circulatio | 1.30136930 |
| 57 | MP0005058_abnormal_lysosome_morphology | 1.29721376 |
| 58 | * MP0002998_abnormal_bone_remodeling | 1.28043020 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.25945702 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.25945702 |
| 61 | MP0002254_reproductive_system_inflammat | 1.25597753 |
| 62 | * MP0003690_abnormal_glial_cell | 1.24590828 |
| 63 | * MP0000716_abnormal_immune_system | 1.24149408 |
| 64 | MP0005408_hypopigmentation | 1.21146939 |
| 65 | MP0003705_abnormal_hypodermis_morpholog | 1.19196858 |
| 66 | MP0003828_pulmonary_edema | 1.18925338 |
| 67 | MP0005310_abnormal_salivary_gland | 1.17315958 |
| 68 | MP0002277_abnormal_respiratory_mucosa | 1.16823989 |
| 69 | MP0005076_abnormal_cell_differentiation | 1.16237418 |
| 70 | MP0009333_abnormal_splenocyte_physiolog | 1.15648575 |
| 71 | MP0005390_skeleton_phenotype | 1.10777597 |
| 72 | MP0000569_abnormal_digit_pigmentation | 1.08502934 |
| 73 | * MP0009763_increased_sensitivity_to | 1.08240804 |
| 74 | MP0003566_abnormal_cell_adhesion | 1.06959711 |
| 75 | MP0002398_abnormal_bone_marrow | 1.05385279 |
| 76 | MP0004272_abnormal_basement_membrane | 1.00068872 |
| 77 | MP0010352_gastrointestinal_tract_polyps | 1.00067610 |
| 78 | MP0005595_abnormal_vascular_smooth | 0.97451133 |
| 79 | MP0005275_abnormal_skin_tensile | 0.92830049 |
| 80 | MP0003172_abnormal_lysosome_physiology | 0.91995492 |
| 81 | MP0005257_abnormal_intraocular_pressure | 0.91283061 |
| 82 | MP0004858_abnormal_nervous_system | 0.90583474 |
| 83 | MP0002429_abnormal_blood_cell | 0.89972694 |
| 84 | MP0003191_abnormal_cellular_cholesterol | 0.86036883 |
| 85 | MP0002090_abnormal_vision | 0.86002345 |
| 86 | MP0001851_eye_inflammation | 0.84403875 |
| 87 | MP0000249_abnormal_blood_vessel | 0.83484181 |
| 88 | MP0008874_decreased_physiological_sensi | 0.81742674 |
| 89 | MP0003646_muscle_fatigue | 0.76693199 |
| 90 | MP0000689_abnormal_spleen_morphology | 0.76106674 |
| 91 | MP0003806_abnormal_nucleotide_metabolis | 0.74071894 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.73680334 |
| 93 | * MP0001501_abnormal_sleep_pattern | 0.73476444 |
| 94 | MP0001958_emphysema | 0.73310309 |
| 95 | MP0000767_abnormal_smooth_muscle | 0.73138027 |
| 96 | MP0002933_joint_inflammation | 0.69817128 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.69761019 |
| 98 | MP0002722_abnormal_immune_system | 0.69598776 |
| 99 | MP0003091_abnormal_cell_migration | 0.69537197 |
| 100 | MP0008875_abnormal_xenobiotic_pharmacok | 0.69292486 |
| 101 | MP0003763_abnormal_thymus_physiology | 0.69132483 |
| 102 | MP0002163_abnormal_gland_morphology | 0.69021843 |
| 103 | MP0003795_abnormal_bone_structure | 0.67850111 |
| 104 | MP0002132_abnormal_respiratory_system | 0.67793214 |
| 105 | MP0003656_abnormal_erythrocyte_physiolo | 0.67764749 |
| 106 | MP0003045_fibrosis | 0.67664593 |
| 107 | MP0008789_abnormal_olfactory_epithelium | 0.66697114 |
| 108 | MP0002166_altered_tumor_susceptibility | 0.66204410 |
| 109 | MP0000750_abnormal_muscle_regeneration | 0.65472304 |
| 110 | MP0001663_abnormal_digestive_system | 0.65341535 |
| 111 | MP0005171_absent_coat_pigmentation | 0.65236533 |
| 112 | MP0005379_endocrine/exocrine_gland_phen | 0.64283738 |
| 113 | MP0000371_diluted_coat_color | 0.64001908 |
| 114 | MP0005647_abnormal_sex_gland | 0.63044621 |
| 115 | MP0008873_increased_physiological_sensi | 0.62878856 |
| 116 | MP0004043_abnormal_pH_regulation | 0.61863954 |
| 117 | MP0002138_abnormal_hepatobiliary_system | 0.61721864 |
| 118 | MP0003279_aneurysm | 0.60322460 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.59397023 |
| 120 | MP0000920_abnormal_myelination | 0.59221943 |
| 121 | MP0002133_abnormal_respiratory_system | 0.55818727 |
| 122 | MP0005388_respiratory_system_phenotype | 0.55818727 |
| 123 | MP0000604_amyloidosis | 0.55666323 |
| 124 | * MP0005535_abnormal_body_temperature | 0.54147644 |
| 125 | MP0005165_increased_susceptibility_to | 0.50427210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.59206784 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.98983901 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.44112085 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.14454796 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 5.73076016 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.73076016 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.73076016 |
| 8 | Increased IgM level (HP:0003496) | 5.16335407 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.84511631 |
| 10 | Prostate neoplasm (HP:0100787) | 4.67262337 |
| 11 | * Mediastinal lymphadenopathy (HP:0100721) | 4.67173994 |
| 12 | Gingivitis (HP:0000230) | 4.60574382 |
| 13 | Autoimmune thrombocytopenia (HP:0001973) | 4.57850326 |
| 14 | Abnormality of macrophages (HP:0004311) | 4.51293133 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 4.25272189 |
| 16 | Stomatitis (HP:0010280) | 4.19372332 |
| 17 | Orchitis (HP:0100796) | 4.12615179 |
| 18 | Basal ganglia calcification (HP:0002135) | 4.11263628 |
| 19 | Vasculitis (HP:0002633) | 4.08169595 |
| 20 | Thick nail (HP:0001805) | 4.08089284 |
| 21 | Systemic lupus erythematosus (HP:0002725) | 4.07126425 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 4.00748741 |
| 23 | Optic neuritis (HP:0100653) | 4.00748741 |
| 24 | Nuclear cataract (HP:0100018) | 3.83514417 |
| 25 | Dysostosis multiplex (HP:0000943) | 3.82010279 |
| 26 | Loss of speech (HP:0002371) | 3.69359751 |
| 27 | Recurrent skin infections (HP:0001581) | 3.64861301 |
| 28 | Myositis (HP:0100614) | 3.56432330 |
| 29 | Periodontitis (HP:0000704) | 3.43356685 |
| 30 | Recurrent fungal infections (HP:0002841) | 3.34888138 |
| 31 | Obstructive lung disease (HP:0006536) | 3.31486099 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 3.31486099 |
| 33 | Urethral obstruction (HP:0000796) | 3.27353199 |
| 34 | Cellulitis (HP:0100658) | 3.23236347 |
| 35 | Disinhibition (HP:0000734) | 3.20240326 |
| 36 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.08389746 |
| 37 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.08389746 |
| 38 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.08389746 |
| 39 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.06721162 |
| 40 | Osteolytic defects of the hand bones (HP:0009699) | 3.06721162 |
| 41 | Neurofibrillary tangles (HP:0002185) | 3.06532352 |
| 42 | Pustule (HP:0200039) | 3.01794420 |
| 43 | Stomach cancer (HP:0012126) | 3.00067820 |
| 44 | Interstitial pulmonary disease (HP:0006530) | 2.98871533 |
| 45 | Hypergammaglobulinemia (HP:0010702) | 2.97889057 |
| 46 | Hematochezia (HP:0002573) | 2.97208919 |
| 47 | Mucopolysacchariduria (HP:0008155) | 2.96281027 |
| 48 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.96281027 |
| 49 | Spondylolisthesis (HP:0003302) | 2.88406334 |
| 50 | Axonal loss (HP:0003447) | 2.81953941 |
| 51 | Amyloidosis (HP:0011034) | 2.76979348 |
| 52 | Autoimmune hemolytic anemia (HP:0001890) | 2.73283705 |
| 53 | Anorexia (HP:0002039) | 2.71923438 |
| 54 | Premature loss of primary teeth (HP:0006323) | 2.71579264 |
| 55 | Thoracolumbar scoliosis (HP:0002944) | 2.71005970 |
| 56 | Myocardial infarction (HP:0001658) | 2.69908709 |
| 57 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.68817093 |
| 58 | Glomerulonephritis (HP:0000099) | 2.68088719 |
| 59 | Pulmonary infiltrates (HP:0002113) | 2.65831335 |
| 60 | Tetraparesis (HP:0002273) | 2.63756397 |
| 61 | Porencephaly (HP:0002132) | 2.63143796 |
| 62 | Recurrent viral infections (HP:0004429) | 2.61930447 |
| 63 | Premature rupture of membranes (HP:0001788) | 2.61029870 |
| 64 | Abnormality of T cell number (HP:0011839) | 2.58722123 |
| 65 | Hemoptysis (HP:0002105) | 2.58194413 |
| 66 | Recurrent pneumonia (HP:0006532) | 2.54925120 |
| 67 | Mutism (HP:0002300) | 2.54355890 |
| 68 | Urticaria (HP:0001025) | 2.53197906 |
| 69 | Protrusio acetabuli (HP:0003179) | 2.52846785 |
| 70 | Poor head control (HP:0002421) | 2.52546054 |
| 71 | Prolonged neonatal jaundice (HP:0006579) | 2.49746957 |
| 72 | Abnormality of the prostate (HP:0008775) | 2.46764682 |
| 73 | Purpura (HP:0000979) | 2.44449246 |
| 74 | Keratoconjunctivitis sicca (HP:0001097) | 2.43277559 |
| 75 | Pigmentary retinal degeneration (HP:0001146) | 2.38086546 |
| 76 | IgA deficiency (HP:0002720) | 2.37190428 |
| 77 | Lower limb hyperreflexia (HP:0002395) | 2.34661404 |
| 78 | Follicular hyperkeratosis (HP:0007502) | 2.31519809 |
| 79 | Vertebral compression fractures (HP:0002953) | 2.30580828 |
| 80 | Progressive neurologic deterioration (HP:0002344) | 2.30364075 |
| 81 | Leukocytosis (HP:0001974) | 2.29279053 |
| 82 | Increased serum ferritin (HP:0003281) | 2.29092801 |
| 83 | Gangrene (HP:0100758) | 2.28089532 |
| 84 | Thin bony cortex (HP:0002753) | 2.26653249 |
| 85 | Alveolar cell carcinoma (HP:0006519) | 2.26439013 |
| 86 | Petechiae (HP:0000967) | 2.25680219 |
| 87 | Recurrent lower respiratory tract infections (HP:0002783) | 2.24531378 |
| 88 | Meningitis (HP:0001287) | 2.23527645 |
| 89 | Keratoconjunctivitis (HP:0001096) | 2.23094513 |
| 90 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.23052868 |
| 91 | Peritonitis (HP:0002586) | 2.22180711 |
| 92 | Osteomyelitis (HP:0002754) | 2.21083977 |
| 93 | Apathy (HP:0000741) | 2.20401086 |
| 94 | Complement deficiency (HP:0004431) | 2.17904585 |
| 95 | Cerebral inclusion bodies (HP:0100314) | 2.17616254 |
| 96 | Asymmetric septal hypertrophy (HP:0001670) | 2.14853788 |
| 97 | Gingival bleeding (HP:0000225) | 2.12818023 |
| 98 | Vacuolated lymphocytes (HP:0001922) | 2.11685670 |
| 99 | Hepatosplenomegaly (HP:0001433) | 2.10103201 |
| 100 | T lymphocytopenia (HP:0005403) | 2.09358353 |
| 101 | Arterial thrombosis (HP:0004420) | 2.09098153 |
| 102 | Polyneuropathy (HP:0001271) | 2.08910282 |
| 103 | Recurrent cutaneous fungal infections (HP:0011370) | 2.08092889 |
| 104 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.08092889 |
| 105 | Cervical subluxation (HP:0003308) | 2.07972040 |
| 106 | Malnutrition (HP:0004395) | 2.07803439 |
| 107 | Diminished motivation (HP:0000745) | 2.07217141 |
| 108 | Episodic fever (HP:0001954) | 2.04620223 |
| 109 | Hemorrhage of the eye (HP:0011885) | 2.03007354 |
| 110 | Eosinophilia (HP:0001880) | 2.02161001 |
| 111 | Chronic sinusitis (HP:0011109) | 2.01628487 |
| 112 | Increased cerebral lipofuscin (HP:0011813) | 2.01571982 |
| 113 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.00387422 |
| 114 | Skin ulcer (HP:0200042) | 2.00230429 |
| 115 | Recurrent bronchitis (HP:0002837) | 1.99881848 |
| 116 | Micronodular cirrhosis (HP:0001413) | 1.98687176 |
| 117 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.97606011 |
| 118 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.97407661 |
| 119 | Aortic dissection (HP:0002647) | 1.95792686 |
| 120 | * Abnormality of the pericardium (HP:0001697) | 1.94375521 |
| 121 | Abnormality of complement system (HP:0005339) | 1.93342706 |
| 122 | Nephritis (HP:0000123) | 1.92057272 |
| 123 | Muscle fiber splitting (HP:0003555) | 1.89589274 |
| 124 | Hypoplasia of the thymus (HP:0000778) | 1.89547919 |
| 125 | Ankle contracture (HP:0006466) | 1.89097477 |
| 126 | Aseptic necrosis (HP:0010885) | 1.87986770 |
| 127 | Metaphyseal irregularity (HP:0003025) | 1.86837974 |
| 128 | Nausea (HP:0002018) | 1.86785906 |
| 129 | Chronic otitis media (HP:0000389) | 1.86596662 |
| 130 | Zonular cataract (HP:0010920) | 1.86048726 |
| 131 | Cheilitis (HP:0100825) | 1.85366574 |
| 132 | * Arthralgia (HP:0002829) | 1.82412724 |
| 133 | Progressive visual loss (HP:0000529) | 1.82136724 |
| 134 | Glomerulopathy (HP:0100820) | 1.81566893 |
| 135 | Submucous cleft hard palate (HP:0000176) | 1.81168278 |
| 136 | Abnormality of the basal ganglia (HP:0002134) | 1.81004627 |
| 137 | Aortic aneurysm (HP:0004942) | 1.80887903 |
| 138 | Acne (HP:0001061) | 1.80362267 |
| 139 | Sepsis (HP:0100806) | 1.79924182 |
| 140 | Parakeratosis (HP:0001036) | 1.78067108 |
| 141 | Persistence of primary teeth (HP:0006335) | 1.77717057 |
| 142 | Femoral bowing (HP:0002980) | 1.77091619 |
| 143 | Emphysema (HP:0002097) | 1.76860523 |
| 144 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.76432260 |
| 145 | Glucose intolerance (HP:0000833) | 1.76349345 |
| 146 | Hyperparathyroidism (HP:0000843) | 1.74841116 |
| 147 | Keratitis (HP:0000491) | 1.74709825 |
| 148 | Vertigo (HP:0002321) | 1.73501492 |
| 149 | Genu recurvatum (HP:0002816) | 1.72710196 |
| 150 | * Abnormality of the pleura (HP:0002103) | 1.72507295 |
| 151 | Flared iliac wings (HP:0002869) | 1.72466673 |
| 152 | Abnormality of T cells (HP:0002843) | 1.71572510 |
| 153 | Chest pain (HP:0100749) | 1.71395158 |
| 154 | Bone pain (HP:0002653) | 1.71198399 |
| 155 | Cleft eyelid (HP:0000625) | 1.70953789 |
| 156 | Blue sclerae (HP:0000592) | 1.70879017 |
| 157 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.67231971 |
| 158 | Vascular tortuosity (HP:0004948) | 1.65463602 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 5.73792043 |
| 2 | MAP3K14 | 5.02542360 |
| 3 | RIPK4 | 4.11990938 |
| 4 | IRAK3 | 3.61459375 |
| 5 | DDR2 | 3.31977643 |
| 6 | IRAK4 | 3.24604518 |
| 7 | JAK3 | 3.22524720 |
| 8 | TBK1 | 3.02132048 |
| 9 | TAOK2 | 3.02060974 |
| 10 | BMPR2 | 2.78609262 |
| 11 | IKBKE | 2.67737634 |
| 12 | LATS2 | 2.63757497 |
| 13 | IKBKB | 2.49051135 |
| 14 | MOS | 2.46124173 |
| 15 | BLK | 2.44218301 |
| 16 | NME2 | 2.38630604 |
| 17 | TYK2 | 2.33631868 |
| 18 | PIM2 | 2.16249301 |
| 19 | EPHA3 | 2.09524210 |
| 20 | EPHB1 | 2.03868570 |
| 21 | TXK | 1.95357530 |
| 22 | TGFBR2 | 1.95338157 |
| 23 | JAK1 | 1.94821502 |
| 24 | MST4 | 1.90728435 |
| 25 | PRPF4B | 1.87110484 |
| 26 | CDC42BPA | 1.60604841 |
| 27 | ERN1 | 1.59813039 |
| 28 | IRAK1 | 1.59541329 |
| 29 | TAOK1 | 1.59039300 |
| 30 | CHUK | 1.56022958 |
| 31 | FRK | 1.55062691 |
| 32 | PDGFRA | 1.43634237 |
| 33 | FGFR4 | 1.43030444 |
| 34 | BMX | 1.40154856 |
| 35 | MAP3K13 | 1.19996807 |
| 36 | ERBB3 | 1.16366695 |
| 37 | CSK | 1.13682311 |
| 38 | EIF2AK2 | 1.12742944 |
| 39 | MAP4K1 | 1.12538873 |
| 40 | NLK | 1.08892918 |
| 41 | STK4 | 1.06156095 |
| 42 | IRAK2 | 1.04494686 |
| 43 | ERBB4 | 1.04320824 |
| 44 | BMPR1B | 1.02900787 |
| 45 | TESK1 | 1.01813453 |
| 46 | ZAK | 1.01019317 |
| 47 | SYK | 0.99947618 |
| 48 | KIT | 0.97816458 |
| 49 | FGR | 0.95914336 |
| 50 | JAK2 | 0.92789390 |
| 51 | ARAF | 0.91736981 |
| 52 | PRKCD | 0.89763975 |
| 53 | ABL2 | 0.89212900 |
| 54 | HCK | 0.88521224 |
| 55 | FGFR3 | 0.88150689 |
| 56 | MYLK | 0.87019267 |
| 57 | MST1R | 0.86033486 |
| 58 | EPHB2 | 0.83963744 |
| 59 | PIM1 | 0.83312530 |
| 60 | MAP3K9 | 0.82329167 |
| 61 | PKN1 | 0.79565685 |
| 62 | LYN | 0.79293040 |
| 63 | BCR | 0.75913909 |
| 64 | RIPK1 | 0.75353911 |
| 65 | BTK | 0.75251333 |
| 66 | SIK3 | 0.74847551 |
| 67 | ZAP70 | 0.73342144 |
| 68 | NEK9 | 0.69262866 |
| 69 | MAP3K5 | 0.66975329 |
| 70 | PAK4 | 0.66489771 |
| 71 | ABL1 | 0.66351254 |
| 72 | NUAK1 | 0.64593280 |
| 73 | LCK | 0.64456889 |
| 74 | ADRBK2 | 0.62560952 |
| 75 | GRK7 | 0.61138875 |
| 76 | YES1 | 0.60608221 |
| 77 | DYRK3 | 0.58342733 |
| 78 | MATK | 0.57883829 |
| 79 | RPS6KA4 | 0.57129336 |
| 80 | MARK3 | 0.56830760 |
| 81 | HIPK2 | 0.56566571 |
| 82 | CSF1R | 0.55503018 |
| 83 | TYRO3 | 0.53777839 |
| 84 | MAPK4 | 0.52899141 |
| 85 | MAPK7 | 0.52354750 |
| 86 | PRKCQ | 0.52004194 |
| 87 | TEC | 0.49973780 |
| 88 | PLK2 | 0.47591657 |
| 89 | AKT3 | 0.47445837 |
| 90 | TAOK3 | 0.47025586 |
| 91 | TRPM7 | 0.46859327 |
| 92 | PRKCE | 0.42299286 |
| 93 | EGFR | 0.42196086 |
| 94 | TTN | 0.41079752 |
| 95 | MAP3K3 | 0.40790261 |
| 96 | PAK2 | 0.38273081 |
| 97 | MAP3K1 | 0.34046497 |
| 98 | RPS6KA5 | 0.33929334 |
| 99 | NEK6 | 0.33533243 |
| 100 | SIK1 | 0.33238074 |
| 101 | RPS6KA1 | 0.33023220 |
| 102 | PTK2 | 0.33016956 |
| 103 | MAP3K12 | 0.32745210 |
| 104 | KSR1 | 0.32502900 |
| 105 | MAP2K3 | 0.30905817 |
| 106 | LIMK1 | 0.30480688 |
| 107 | EIF2AK3 | 0.30252501 |
| 108 | CLK1 | 0.30165100 |
| 109 | MAPKAPK2 | 0.28345476 |
| 110 | MET | 0.27562849 |
| 111 | PDGFRB | 0.25726816 |
| 112 | TNK2 | 0.25215127 |
| 113 | STK10 | 0.24327206 |
| 114 | FYN | 0.23395181 |
| 115 | KSR2 | 0.23241489 |
| 116 | ERBB2 | 0.22506225 |
| 117 | DAPK2 | 0.22061689 |
| 118 | BRAF | 0.21167403 |
| 119 | EPHA2 | 0.20912579 |
| 120 | PDPK1 | 0.20416536 |
| 121 | MELK | 0.20236417 |
| 122 | MAP3K11 | 0.19530669 |
| 123 | IGF1R | 0.19208092 |
| 124 | CDK6 | 0.19105889 |
| 125 | STK3 | 0.18150014 |
| 126 | MAP3K2 | 0.17266981 |
| 127 | ALK | 0.17170669 |
| 128 | INSR | 0.16877024 |
| 129 | DAPK3 | 0.16457418 |
| 130 | GSK3A | 0.15859857 |
| 131 | ADRBK1 | 0.14855317 |
| 132 | MAPKAPK5 | 0.14200879 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 4.35665207 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.86083581 |
| 3 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.54408020 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.49691547 |
| 5 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.03792290 |
| 6 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.95460304 |
| 7 | * Legionellosis_Homo sapiens_hsa05134 | 2.87985036 |
| 8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.67823790 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.67344557 |
| 10 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.62571086 |
| 11 | * Pertussis_Homo sapiens_hsa05133 | 2.48709427 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.45978323 |
| 13 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.41313690 |
| 14 | * Malaria_Homo sapiens_hsa05144 | 2.34944392 |
| 15 | * African trypanosomiasis_Homo sapiens_hsa05143 | 2.31569193 |
| 16 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.24196761 |
| 17 | * TNF signaling pathway_Homo sapiens_hsa04668 | 2.13265095 |
| 18 | Asthma_Homo sapiens_hsa05310 | 2.11796998 |
| 19 | * Measles_Homo sapiens_hsa05162 | 2.00127732 |
| 20 | * Influenza A_Homo sapiens_hsa05164 | 1.94239674 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.92330846 |
| 22 | * Tuberculosis_Homo sapiens_hsa05152 | 1.90478443 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.80598209 |
| 24 | * Salmonella infection_Homo sapiens_hsa05132 | 1.78249700 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.76490010 |
| 26 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.68072073 |
| 27 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.67391539 |
| 28 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.60878730 |
| 29 | Bladder cancer_Homo sapiens_hsa05219 | 1.47133504 |
| 30 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.44986557 |
| 31 | Phagosome_Homo sapiens_hsa04145 | 1.42336860 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41536617 |
| 33 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33144712 |
| 34 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.26737078 |
| 35 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.21801786 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18472440 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.14015387 |
| 38 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10433597 |
| 39 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02661919 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.02636214 |
| 41 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.00462624 |
| 42 | * Prion diseases_Homo sapiens_hsa05020 | 0.98392908 |
| 43 | * Amoebiasis_Homo sapiens_hsa05146 | 0.96657953 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 0.89917410 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.84477554 |
| 46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.81672824 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 0.79759096 |
| 48 | * Hepatitis B_Homo sapiens_hsa05161 | 0.79418940 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 0.78782073 |
| 50 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.78080352 |
| 51 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.72541387 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72507973 |
| 53 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.71597407 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.68705553 |
| 55 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68001470 |
| 56 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.66891784 |
| 57 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.66864432 |
| 58 | Mineral absorption_Homo sapiens_hsa04978 | 0.66851227 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66800979 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64813131 |
| 61 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60887178 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58982907 |
| 63 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.58624421 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58182234 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54740184 |
| 66 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54698291 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52714665 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51074951 |
| 69 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.45812595 |
| 70 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.44736863 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43619962 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43140302 |
| 73 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41905096 |
| 74 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.41764916 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39938619 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39740312 |
| 77 | ABC transporters_Homo sapiens_hsa02010 | 0.39410458 |
| 78 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.38932077 |
| 79 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36880302 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.36730109 |
| 81 | Focal adhesion_Homo sapiens_hsa04510 | 0.36610631 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35319747 |
| 83 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.32351561 |
| 84 | Proteasome_Homo sapiens_hsa03050 | 0.31685284 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30904599 |
| 86 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.30547664 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30480113 |
| 88 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.30105621 |
| 89 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.29811747 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28417752 |
| 91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28374626 |
| 92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.27095594 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.26913985 |
| 94 | Prostate cancer_Homo sapiens_hsa05215 | 0.26184641 |
| 95 | Platelet activation_Homo sapiens_hsa04611 | 0.25317679 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24960938 |
| 97 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.24423908 |
| 98 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.24090064 |
| 99 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.23231968 |
| 100 | * Insulin resistance_Homo sapiens_hsa04931 | 0.22814423 |
| 101 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.22315820 |
| 102 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.20580494 |
| 103 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.20446574 |
| 104 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.20427404 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.20031759 |
| 106 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.19369391 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.19095406 |
| 108 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.14934874 |
| 109 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.13865584 |
| 110 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.12716108 |
| 111 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.11819717 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.09209033 |
| 113 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.08924412 |
| 114 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.08867662 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.07689312 |
| 116 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.07372165 |
| 117 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.07184755 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.06406970 |
| 119 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.06272213 |
| 120 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.05272988 |
| 121 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.04649417 |
| 122 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.04486728 |

